CN105055804A - Traditional Chinese medicine composition for treating lumbar disc herniation - Google Patents
Traditional Chinese medicine composition for treating lumbar disc herniation Download PDFInfo
- Publication number
- CN105055804A CN105055804A CN201510557557.XA CN201510557557A CN105055804A CN 105055804 A CN105055804 A CN 105055804A CN 201510557557 A CN201510557557 A CN 201510557557A CN 105055804 A CN105055804 A CN 105055804A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating lumbar disc herniation, which comprises the following substances in parts by weight: 100-150 parts of angelica, 120-150 parts of chuanxiong rhizome, 100-150 parts of white peony root, 100-150 parts of prepared rehmannia root, 120-150 parts of pubescent angelica root, 100-150 parts of mistletoe, 100-150 parts of dipsacus root, 100-150 parts of cyathula root, 150-200 parts of clematis root, 100-120 parts of gentiana macrophylla, 100-150 parts of spatholobus stem, 200-250 parts of astragalus root, 90-120 parts of frankincense, 90-120 parts of myrrh, 120-150 parts of Chinese atractylodes, 100-150 parts of phellodendron bark, 120-150 parts of fried bighead atractylodes rhizome, 50-90 parts of small fennel, 120-150 parts of dangshen, 120-150 parts of tuckahoe, 100-150 parts of licorice, 100-120 parts of nutgrass galingale rhizome, 125-160 parts of red sage root, 100-120 parts of cibotium barometz, 120-150 parts of kudzu root, 90-120 parts of notopterygium root, 100-120 parts of corydalis tuber, 100-120 parts of dragon blood, 30-50 parts of nux vomica, 120-180 parts of eucommia, 100-120 parts of peach kernel, 90-120 parts of safflower, 100-120 parts of homalomena rhizoma, 100-120 parts of caulis sinomenii and 100-120 parts of pawpaw. The traditional Chinese medicine composition provided by the invention has obvious curative effects and is very worthy of being widely generalized by interaction and synergism of the traditional Chinese medicines.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition of nursing for treating prolapse of lumbar intervertebral disc.
Background technology
Prolapse of lumbar intervertebral disc is one of comparatively common clinically lumbar disease, and it is the diagnosis of doctor trained in Western medicine, and the traditional Chinese medical science does not have this name of disease.But this disease system is attributed in " lumbago ", " lumbago and skelalgia " this category.Primary disease is commonly encountered diseases, the frequently-occurring disease of orthopedics department.Mainly because lumbar intervertebral disc each several part (vertebral pulp, fibrous ring and cartilaginous lamina, especially vertebral pulp), after having degenerative change in various degree, under the effect of extraneous factor, the Anular disruption of intervertebral disc, nucleus pulposus is from part outstanding (or deviating from) of breaking in rear or intraspinal tube, cause adjacent tissue, stimulated as spinal nerve root, spinal cord etc. or oppressed, thus being produced flank pain, a series of clinical symptoms such as side lower limb or two numbness of lower limbs, pain.
At present, the Therapeutic Method of prolapse of lumbar intervertebral disc is a lot.Traction, acupuncture or massage can not be cured, and the vertebral pulp given prominence to also can not be made to eliminate, but the effect life-time service that can play auxiliary treatment are very disadvantageous; And operation mainly takes to excise outstanding vertebral pulp, but the fibrous ring of breaking still is not restored and local metabolic does not improve, may recur at any time, just can not again cure, so blindly operation had better not be used when expectant treatment can be cured once recurrence.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc, it comprises the material of following weight portion: Radix Angelicae Sinensis 100-150 part, Rhizoma Chuanxiong 120-150 part, Radix Paeoniae Alba 100-150 part, Radix Rehmanniae Preparata 100-150 part, Radix Angelicae Pubescentis 120-150 part, Herba Taxilli 100-150 part, Radix Dipsaci 100-150 part, Radix Cyathulae 100-150 part, Radix Clematidis 150-200 part, Radix Gentianae Macrophyllae 100-120 part, Caulis Spatholobi 100-150 part, Radix Astragali 200-250 part, Olibanum 90-120 part, Myrrha 90-120 part, Rhizoma Atractylodis 120-150 part, Cortex Phellodendri 100-150 part, Rhizoma Atractylodis Macrocephalae (parched) 120-150 part, Fructus Foeniculi 50-90 part, Radix Codonopsis 120-150 part, Poria 120-150 part, Radix Glycyrrhizae 100-150 part, Rhizoma Cyperi 100-120 part, Radix Salviae Miltiorrhizae 125-160 part, Rhizoma Cibotii 100-120 part, Radix Puerariae 120-150 part, Rhizoma Et Radix Notopterygii 90-120 part, Rhizoma Corydalis 100-120 part, Sanguis Draxonis 100-120 part, Semen Strychni 30-50 part, Cortex Eucommiae 120-180 part, Semen Persicae 100-120 part, Flos Carthami 90-120 part, Rhizoma Homalomenae 100-120 part, Caulis Sinomenii 100-120 part and Fructus Chaenomelis 100-120 part.
Preferably, the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc of the present invention comprises the material of following weight portion: Radix Angelicae Sinensis 120 parts, Rhizoma Chuanxiong 130 parts, the Radix Paeoniae Alba 120 parts, 120 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 130 parts, Herba Taxilli 120 parts, Radix Dipsaci 120 parts, Radix Cyathulae 120 parts, Radix Clematidis 180 parts, Radix Gentianae Macrophyllae 110 parts, Caulis Spatholobi 120 parts, the Radix Astragali 230 parts, Olibanum 100 parts, Myrrha 100 parts, Rhizoma Atractylodis 130 parts, Cortex Phellodendri 130 parts, Rhizoma Atractylodis Macrocephalae (parched) 130 parts, Fructus Foeniculi 70 parts, Radix Codonopsis 130 parts, 130 parts, Poria, 130 parts, Radix Glycyrrhizae, Rhizoma Cyperi 110 parts, Radix Salviae Miltiorrhizae 140 parts, Rhizoma Cibotii 110 parts, Radix Puerariae 130 parts, Rhizoma Et Radix Notopterygii 100 parts, Rhizoma Corydalis 110 parts, Sanguis Draxonis 110 parts, Semen Strychni 40 parts, the Cortex Eucommiae 150 parts, 110 parts, Semen Persicae, 100 parts, Flos Carthami, Rhizoma Homalomenae 110 parts, Caulis Sinomenii 110 parts and Fructus Chaenomelis 110 parts.
More preferably, the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc of the present invention also comprises the material of following weight portion: asparagus 110 parts, Caulis Sargentodoxae 120 parts, Rhizoma Tupistrae Chinensis 130 parts, Semen Cuscutae 150 parts, Radix Rhododendri 100 parts, Folium Microcoris paniculatae 90 parts, Equisetum sylvaticum L. 100 parts, Lignum Acronychiae 110 parts, Drymotaenium miyoshianum (Mak.) Mak. 110 parts, Radix Tylophorae arenicolae 100 parts, globule grass 120 parts, Cortex Meliosmatis rigidae Radicis 100 parts and Herb Gynostemmae Pentaphylli 120 parts.
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or ointment.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment prolapse of lumbar intervertebral disc, and described compositions comprises the material of following weight portion: Radix Angelicae Sinensis 100-150 part, Rhizoma Chuanxiong 120-150 part, Radix Paeoniae Alba 100-150 part, Radix Rehmanniae Preparata 100-150 part, Radix Angelicae Pubescentis 120-150 part, Herba Taxilli 100-150 part, Radix Dipsaci 100-150 part, Radix Cyathulae 100-150 part, Radix Clematidis 150-200 part, Radix Gentianae Macrophyllae 100-120 part, Caulis Spatholobi 100-150 part, Radix Astragali 200-250 part, Olibanum 90-120 part, Myrrha 90-120 part, Rhizoma Atractylodis 120-150 part, Cortex Phellodendri 100-150 part, Rhizoma Atractylodis Macrocephalae (parched) 120-150 part, Fructus Foeniculi 50-90 part, Radix Codonopsis 120-150 part, Poria 120-150 part, Radix Glycyrrhizae 100-150 part, Rhizoma Cyperi 100-120 part, Radix Salviae Miltiorrhizae 125-160 part, Rhizoma Cibotii 100-120 part, Radix Puerariae 120-150 part, Rhizoma Et Radix Notopterygii 90-120 part, Rhizoma Corydalis 100-120 part, Sanguis Draxonis 100-120 part, Semen Strychni 30-50 part, Cortex Eucommiae 120-180 part, Semen Persicae 100-120 part, Flos Carthami 90-120 part, Rhizoma Homalomenae 100-120 part, Caulis Sinomenii 100-120 part and Fructus Chaenomelis 100-120 part.
Preferably, described compositions comprises the material of following weight portion: Radix Angelicae Sinensis 120 parts, Rhizoma Chuanxiong 130 parts, the Radix Paeoniae Alba 120 parts, 120 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 130 parts, Herba Taxilli 120 parts, Radix Dipsaci 120 parts, Radix Cyathulae 120 parts, Radix Clematidis 180 parts, Radix Gentianae Macrophyllae 110 parts, Caulis Spatholobi 120 parts, the Radix Astragali 230 parts, Olibanum 100 parts, Myrrha 100 parts, Rhizoma Atractylodis 130 parts, Cortex Phellodendri 130 parts, Rhizoma Atractylodis Macrocephalae (parched) 130 parts, Fructus Foeniculi 70 parts, Radix Codonopsis 130 parts, 130 parts, Poria, 130 parts, Radix Glycyrrhizae, Rhizoma Cyperi 110 parts, Radix Salviae Miltiorrhizae 140 parts, Rhizoma Cibotii 110 parts, Radix Puerariae 130 parts, Rhizoma Et Radix Notopterygii 100 parts, Rhizoma Corydalis 110 parts, Sanguis Draxonis 110 parts, Semen Strychni 40 parts, the Cortex Eucommiae 150 parts, 110 parts, Semen Persicae, 100 parts, Flos Carthami, Rhizoma Homalomenae 110 parts, Caulis Sinomenii 110 parts and Fructus Chaenomelis 110 parts.
More preferably, described compositions also comprises the material of following weight portion: asparagus 110 parts, Caulis Sargentodoxae 120 parts, Rhizoma Tupistrae Chinensis 130 parts, Semen Cuscutae 150 parts, Radix Rhododendri 100 parts, Folium Microcoris paniculatae 90 parts, Equisetum sylvaticum L. 100 parts, Lignum Acronychiae 110 parts, Drymotaenium miyoshianum (Mak.) Mak. 110 parts, Radix Tylophorae arenicolae 100 parts, globule grass 120 parts, Cortex Meliosmatis rigidae Radicis 100 parts and Herb Gynostemmae Pentaphylli 120 parts.
Most preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or ointment
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 ointment of the present invention
Take Radix Angelicae Sinensis 120 grams, Rhizoma Chuanxiong 130 grams, the Radix Paeoniae Alba 120 grams, 120 grams, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 130 grams, Herba Taxilli 120 grams, Radix Dipsaci 120 grams, Radix Cyathulae 120 grams, Radix Clematidis 180 grams, Radix Gentianae Macrophyllae 110 grams, Caulis Spatholobi 120 grams, the Radix Astragali 230 grams, Olibanum 100 grams, Myrrha 100 grams, Rhizoma Atractylodis 130 grams, Cortex Phellodendri 130 grams, Rhizoma Atractylodis Macrocephalae (parched) 130 grams, Fructus Foeniculi 70 grams, Radix Codonopsis 130 grams, 130 grams, Poria, 130 grams, Radix Glycyrrhizae, Rhizoma Cyperi 110 grams, Radix Salviae Miltiorrhizae 140 grams, Rhizoma Cibotii 110 grams, Radix Puerariae 130 grams, Rhizoma Et Radix Notopterygii 100 grams, Rhizoma Corydalis 110 grams, Sanguis Draxonis 110 grams, Semen Strychni 40 grams, the Cortex Eucommiae 150 grams, 110 grams, Semen Persicae, 100 grams, Flos Carthami, Rhizoma Homalomenae 110 grams, Caulis Sinomenii 110 grams and Fructus Chaenomelis 110 grams, add 25000 ml waters, heating 5 hours under the condition of backflow, filter, filtrate is made to be cooled to room temperature, adding dehydrated alcohol to alcohol content is 85 volume %, hold over night, filter, by filtrate evaporate to dryness, pulverize, add 1200 grams, vaseline, mix homogeneously, obtain.
Embodiment 2 ointment of the present invention
Take Radix Angelicae Sinensis 120 grams, Rhizoma Chuanxiong 130 grams, the Radix Paeoniae Alba 120 grams, 120 grams, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 130 grams, Herba Taxilli 120 grams, Radix Dipsaci 120 grams, Radix Cyathulae 120 grams, Radix Clematidis 180 grams, Radix Gentianae Macrophyllae 110 grams, Caulis Spatholobi 120 grams, the Radix Astragali 230 grams, Olibanum 100 grams, Myrrha 100 grams, Rhizoma Atractylodis 130 grams, Cortex Phellodendri 130 grams, Rhizoma Atractylodis Macrocephalae (parched) 130 grams, Fructus Foeniculi 70 grams, Radix Codonopsis 130 grams, 130 grams, Poria, 130 grams, Radix Glycyrrhizae, Rhizoma Cyperi 110 grams, Radix Salviae Miltiorrhizae 140 grams, Rhizoma Cibotii 110 grams, Radix Puerariae 130 grams, Rhizoma Et Radix Notopterygii 100 grams, Rhizoma Corydalis 110 grams, Sanguis Draxonis 110 grams, Semen Strychni 40 grams, the Cortex Eucommiae 150 grams, 110 grams, Semen Persicae, 100 grams, Flos Carthami, Rhizoma Homalomenae 110 grams, Caulis Sinomenii 110 grams, Fructus Chaenomelis 110 grams, asparagus 110 grams, Caulis Sargentodoxae 120 grams, Rhizoma Tupistrae Chinensis 130 grams, Semen Cuscutae 150 grams, Radix Rhododendri 100 grams, Folium Microcoris paniculatae 90 grams, Equisetum sylvaticum L. 100 grams, Lignum Acronychiae 110 grams, Drymotaenium miyoshianum (Mak.) Mak. 110 grams, Radix Tylophorae arenicolae 100 grams, globule grass 120 grams, Cortex Meliosmatis rigidae Radicis 100 grams and Herb Gynostemmae Pentaphylli 120 grams, add 25000 ml waters, heating 5 hours under the condition of backflow, filter, make filtrate be cooled to room temperature, adding dehydrated alcohol to alcohol content is 85 volume %, hold over night, filter, by filtrate evaporate to dryness, pulverize, add 1200 grams, vaseline, mix homogeneously, to obtain final product.
Experimental example
Diagnostic criteria
The diagnosis of all patients is all according to the diagnostic criteria about cold-dampness type prolapse of lumbar intervertebral disc in " disease of tcm curative effect is for standard ":
(1) there are waist wound, chronic strain or are subject to cold-damp history.Major part patient has chronic back pain history at premorbid.
(2) often person between twenty and fifty are betided.
(3) lumbago is to buttocks and lower limb radiation, and when abdominal pressure increases (as cough, sneeze), pain increases the weight of.
(4) scoliosis, waist physiology radians disappears, and diseased region vertebra is other tenderness, and to lower limb radiation, waist limitation of activity.
(5) the lower limb innervation district that gets involved feels irritated or blunt, and course of disease elder can occur amyotrophy.Leg raising straight or the reinforcement test positive, knee joint, Achilles tendon reflex weaken or disappear, and big toe dorsiflexion power weakens.
(6) x-ray takes the photograph sheet inspection: scoliosis, and waist physiology lordosis disappears, and pathological interspinal dish may narrow, and neighboring edge has osteophytosis.CT examination can show position and the degree of intervertebral disk hernia.
TCM syndrome is cold-damp syndrome: waist lower limb cold type of pain weighs, and changes one's position unfavorable, and the pain that reposes does not subtract, and catch cold and wet weather increases the weight of, limbs are sent out cool.Pale tongue, Tai Bai or greasy, deep and tense pulse or slow.Pathological:
(1) one-sided intervertebral disk hernia: low back pain companion side lower limb radiating pain, scoliosis, waist physiology lordosis reduces or disappears, and the other pressure of pathological interspinal dish Ipsilateral vertebra is gushed, and can radiate along sciatic nerve to lower limb, straight-leg raising test is positive.CT examination: intervertebral disc is outstanding to canalis spinalis side.
(2) bilateral prolapse of intervertebral disc: low back pain, companion's bilateral lower limb radiating pain, waist physiology lordosis reduces or disappears, and pathological interspinal dish both sides vertebra is other all has tenderness, can radiate along sciatic nerve to lower limb, and two lower limb straight-leg raising test is positive.CT examination: outstanding about intervertebral disc meat, and the block that dissociates as seen.
(3), the cauda equina nerve stress disorders such as perineal position numbness and fecal and urinary functions obstacle can also be there is in central type prolapse of intervertebral disc: except the symptom occurring lumbago and skelalgia.CT examination: intervertebral disc is outstanding to direction, center.
(4) upper mo(u)ld bottom half prolapse of intervertebral disc: most of patient only has lumbago symptom, the visible Schmori tuberosity of X-ray examination pathological interspinal dish.
Exclusion standard: the patient getting rid of gravidic women, rheumarthrosis, three-hypers, osteoporosis.
According to above-mentioned standard, select 100 routine prolapse of lumbar intervertebral disc patients, wherein man 58 example, female 42 example, age 31-65 year, average 45 years old.Be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 50 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 to use in embodiment 1 ointment of preparation to treat, every day twice, uses 10 grams of ointment uniform application to deviate from position, treatment 50 days continuously patient at every turn.
Treatment group 2 to use in embodiment 2 ointment of preparation to treat, every day twice, uses 10 grams of ointment uniform application to deviate from position, treatment 50 days continuously patient at every turn.
Criterion of therapeutical effect
" the new Chinese medicine guideline of clinical investigations " the 3rd volume " guideline of clinical investigations of new Chinese medicine treatment prolapse of lumbar intervertebral disc " promulgated for 1997 by Ministry of Health of the People's Republic of China judges.
1. clinical recovery: lumbago and skelalgia disappears substantially, Negative straight-leg raising test, recover normally to work symptom, somatic feature score improvement rate is more than 95%.
2. effective: flank pain partial disappearance, without obvious pressure pain point, Negative straight-leg raising test, basic recovery normally works, and symptom, somatic feature score improvement rate are at 65%-95%.
3. effective: to have slight lumbago and skelalgia, straight-leg raising test is positive, and part is resumed work, and symptom, somatic feature score improvement rate are at 30%-65%.
4. invalid: lumbago and skelalgia is without improvement, and straight-leg raising test is positive, and not competent work, symptom, somatic feature score improvement rate are below 30%.
Statistical method
Utilize SPSS13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts x
2inspection, P < 0.05 represents that difference has statistical significance.
Result
Through treatment, for treatment group 1, clinical recovery 19 example, effective 12 examples, effective 13 examples, invalid 6 examples, total effective rate is 88%, and for treatment group 2, clinical recovery 26 example, effective 15 examples, effective 9 examples, total effective rate is 100%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).And two groups of patients all do not find obvious untoward reaction over the course for the treatment of.
Claims (8)
1. treat a Chinese medicine composition for prolapse of lumbar intervertebral disc, it is characterized in that, it comprises the material of following weight portion: Radix Angelicae Sinensis 100-150 part, Rhizoma Chuanxiong 120-150 part, Radix Paeoniae Alba 100-150 part, Radix Rehmanniae Preparata 100-150 part, Radix Angelicae Pubescentis 120-150 part, Herba Taxilli 100-150 part, Radix Dipsaci 100-150 part, Radix Cyathulae 100-150 part, Radix Clematidis 150-200 part, Radix Gentianae Macrophyllae 100-120 part, Caulis Spatholobi 100-150 part, Radix Astragali 200-250 part, Olibanum 90-120 part, Myrrha 90-120 part, Rhizoma Atractylodis 120-150 part, Cortex Phellodendri 100-150 part, Rhizoma Atractylodis Macrocephalae (parched) 120-150 part, Fructus Foeniculi 50-90 part, Radix Codonopsis 120-150 part, Poria 120-150 part, Radix Glycyrrhizae 100-150 part, Rhizoma Cyperi 100-120 part, Radix Salviae Miltiorrhizae 125-160 part, Rhizoma Cibotii 100-120 part, Radix Puerariae 120-150 part, Rhizoma Et Radix Notopterygii 90-120 part, Rhizoma Corydalis 100-120 part, Sanguis Draxonis 100-120 part, Semen Strychni 30-50 part, Cortex Eucommiae 120-180 part, Semen Persicae 100-120 part, Flos Carthami 90-120 part, Rhizoma Homalomenae 100-120 part, Caulis Sinomenii 100-120 part and Fructus Chaenomelis 100-120 part.
2. the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc according to claim 1, it is characterized in that, it comprises the material of following weight portion: Radix Angelicae Sinensis 120 parts, Rhizoma Chuanxiong 130 parts, the Radix Paeoniae Alba 120 parts, 120 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 130 parts, Herba Taxilli 120 parts, Radix Dipsaci 120 parts, Radix Cyathulae 120 parts, Radix Clematidis 180 parts, Radix Gentianae Macrophyllae 110 parts, Caulis Spatholobi 120 parts, the Radix Astragali 230 parts, Olibanum 100 parts, Myrrha 100 parts, Rhizoma Atractylodis 130 parts, Cortex Phellodendri 130 parts, Rhizoma Atractylodis Macrocephalae (parched) 130 parts, Fructus Foeniculi 70 parts, Radix Codonopsis 130 parts, 130 parts, Poria, 130 parts, Radix Glycyrrhizae, Rhizoma Cyperi 110 parts, Radix Salviae Miltiorrhizae 140 parts, Rhizoma Cibotii 110 parts, Radix Puerariae 130 parts, Rhizoma Et Radix Notopterygii 100 parts, Rhizoma Corydalis 110 parts, Sanguis Draxonis 110 parts, Semen Strychni 40 parts, the Cortex Eucommiae 150 parts, 110 parts, Semen Persicae, 100 parts, Flos Carthami, Rhizoma Homalomenae 110 parts, Caulis Sinomenii 110 parts and Fructus Chaenomelis 110 parts.
3. the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: asparagus 110 parts, Caulis Sargentodoxae 120 parts, Rhizoma Tupistrae Chinensis 130 parts, Semen Cuscutae 150 parts, Radix Rhododendri 100 parts, Folium Microcoris paniculatae 90 parts, Equisetum sylvaticum L. 100 parts, Lignum Acronychiae 110 parts, Drymotaenium miyoshianum (Mak.) Mak. 110 parts, Radix Tylophorae arenicolae 100 parts, globule grass 120 parts, Cortex Meliosmatis rigidae Radicis 100 parts and Herb Gynostemmae Pentaphylli 120 parts.
4. the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or ointment.
5. the purposes of compositions in the Chinese medicine of preparation treatment prolapse of lumbar intervertebral disc, it is characterized in that, described compositions comprises the material of following weight portion: Radix Angelicae Sinensis 100-150 part, Rhizoma Chuanxiong 120-150 part, Radix Paeoniae Alba 100-150 part, Radix Rehmanniae Preparata 100-150 part, Radix Angelicae Pubescentis 120-150 part, Herba Taxilli 100-150 part, Radix Dipsaci 100-150 part, Radix Cyathulae 100-150 part, Radix Clematidis 150-200 part, Radix Gentianae Macrophyllae 100-120 part, Caulis Spatholobi 100-150 part, Radix Astragali 200-250 part, Olibanum 90-120 part, Myrrha 90-120 part, Rhizoma Atractylodis 120-150 part, Cortex Phellodendri 100-150 part, Rhizoma Atractylodis Macrocephalae (parched) 120-150 part, Fructus Foeniculi 50-90 part, Radix Codonopsis 120-150 part, Poria 120-150 part, Radix Glycyrrhizae 100-150 part, Rhizoma Cyperi 100-120 part, Radix Salviae Miltiorrhizae 125-160 part, Rhizoma Cibotii 100-120 part, Radix Puerariae 120-150 part, Rhizoma Et Radix Notopterygii 90-120 part, Rhizoma Corydalis 100-120 part, Sanguis Draxonis 100-120 part, Semen Strychni 30-50 part, Cortex Eucommiae 120-180 part, Semen Persicae 100-120 part, Flos Carthami 90-120 part, Rhizoma Homalomenae 100-120 part, Caulis Sinomenii 100-120 part and Fructus Chaenomelis 100-120 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Radix Angelicae Sinensis 120 parts, Rhizoma Chuanxiong 130 parts, the Radix Paeoniae Alba 120 parts, 120 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 130 parts, Herba Taxilli 120 parts, Radix Dipsaci 120 parts, Radix Cyathulae 120 parts, Radix Clematidis 180 parts, Radix Gentianae Macrophyllae 110 parts, Caulis Spatholobi 120 parts, the Radix Astragali 230 parts, Olibanum 100 parts, Myrrha 100 parts, Rhizoma Atractylodis 130 parts, Cortex Phellodendri 130 parts, Rhizoma Atractylodis Macrocephalae (parched) 130 parts, Fructus Foeniculi 70 parts, Radix Codonopsis 130 parts, 130 parts, Poria, 130 parts, Radix Glycyrrhizae, Rhizoma Cyperi 110 parts, Radix Salviae Miltiorrhizae 140 parts, Rhizoma Cibotii 110 parts, Radix Puerariae 130 parts, Rhizoma Et Radix Notopterygii 100 parts, Rhizoma Corydalis 110 parts, Sanguis Draxonis 110 parts, Semen Strychni 40 parts, the Cortex Eucommiae 150 parts, 110 parts, Semen Persicae, 100 parts, Flos Carthami, Rhizoma Homalomenae 110 parts, Caulis Sinomenii 110 parts and Fructus Chaenomelis 110 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: asparagus 110 parts, Caulis Sargentodoxae 120 parts, Rhizoma Tupistrae Chinensis 130 parts, Semen Cuscutae 150 parts, Radix Rhododendri 100 parts, Folium Microcoris paniculatae 90 parts, Equisetum sylvaticum L. 100 parts, Lignum Acronychiae 110 parts, Drymotaenium miyoshianum (Mak.) Mak. 110 parts, Radix Tylophorae arenicolae 100 parts, globule grass 120 parts, Cortex Meliosmatis rigidae Radicis 100 parts and Herb Gynostemmae Pentaphylli 120 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510557557.XA CN105055804A (en) | 2015-09-06 | 2015-09-06 | Traditional Chinese medicine composition for treating lumbar disc herniation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510557557.XA CN105055804A (en) | 2015-09-06 | 2015-09-06 | Traditional Chinese medicine composition for treating lumbar disc herniation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105055804A true CN105055804A (en) | 2015-11-18 |
Family
ID=54485481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510557557.XA Pending CN105055804A (en) | 2015-09-06 | 2015-09-06 | Traditional Chinese medicine composition for treating lumbar disc herniation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105055804A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435203A (en) * | 2016-01-05 | 2016-03-30 | 韩龙章 | Hand-held health-care Chinese medicinal composition and preparation method thereof |
| CN105663913A (en) * | 2016-01-30 | 2016-06-15 | 接栋琪 | Traditional Chinese medicine composition for treating lumbar disc herniation |
| CN105816822A (en) * | 2016-05-25 | 2016-08-03 | 刘金海 | Traditional Chinese medicine composition for treating lumbar disc herniation |
| CN105878667A (en) * | 2016-06-15 | 2016-08-24 | 李竹青 | Medicine for treating lumbar intervertebral disc herniation and preparation method thereof |
| CN105920434A (en) * | 2016-05-17 | 2016-09-07 | 周学前 | Traditional Chinese medicinal composition for treating protrusion of lumbar intervertebral disc |
| CN105998546A (en) * | 2016-06-16 | 2016-10-12 | 万朝霞 | Traditional Chinese medicine composition |
| CN106139005A (en) * | 2016-08-01 | 2016-11-23 | 邓炳章 | A kind of Chinese medicine composition treating prolapse of lumbar intervertebral disc |
| CN108404043A (en) * | 2018-04-25 | 2018-08-17 | 贵州苗草堂生物科技有限公司 | A kind of Chinese medicine composition and preparation method thereof |
| CN112656899A (en) * | 2021-01-25 | 2021-04-16 | 余俊严 | Pharmaceutical composition for treating neck, shoulder, waist and leg pain and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002265356A (en) * | 2001-03-14 | 2002-09-18 | Mitsubishi Pharma Corp | Agent for treating and/or preventing pain of lumbar vertebra herniated intervertebral disk |
| CN104225381A (en) * | 2013-06-23 | 2014-12-24 | 陈冠卿 | Medicine for treating protrusion of lumbar intervertebral disc |
-
2015
- 2015-09-06 CN CN201510557557.XA patent/CN105055804A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002265356A (en) * | 2001-03-14 | 2002-09-18 | Mitsubishi Pharma Corp | Agent for treating and/or preventing pain of lumbar vertebra herniated intervertebral disk |
| CN104225381A (en) * | 2013-06-23 | 2014-12-24 | 陈冠卿 | Medicine for treating protrusion of lumbar intervertebral disc |
Non-Patent Citations (3)
| Title |
|---|
| 宋政昌: "椎突丸治疗腰椎间盘突出症187例", 《光明中医》 * |
| 曾飞云: "中西医结合治疗腰椎间盘突出症66例", 《光明中医》 * |
| 谭高文等: "综合治疗腰椎间盘突出症102例", 《湖南中医杂志》 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435203A (en) * | 2016-01-05 | 2016-03-30 | 韩龙章 | Hand-held health-care Chinese medicinal composition and preparation method thereof |
| CN105663913A (en) * | 2016-01-30 | 2016-06-15 | 接栋琪 | Traditional Chinese medicine composition for treating lumbar disc herniation |
| CN105920434A (en) * | 2016-05-17 | 2016-09-07 | 周学前 | Traditional Chinese medicinal composition for treating protrusion of lumbar intervertebral disc |
| CN105816822A (en) * | 2016-05-25 | 2016-08-03 | 刘金海 | Traditional Chinese medicine composition for treating lumbar disc herniation |
| CN105878667A (en) * | 2016-06-15 | 2016-08-24 | 李竹青 | Medicine for treating lumbar intervertebral disc herniation and preparation method thereof |
| CN105998546A (en) * | 2016-06-16 | 2016-10-12 | 万朝霞 | Traditional Chinese medicine composition |
| CN106139005A (en) * | 2016-08-01 | 2016-11-23 | 邓炳章 | A kind of Chinese medicine composition treating prolapse of lumbar intervertebral disc |
| CN108404043A (en) * | 2018-04-25 | 2018-08-17 | 贵州苗草堂生物科技有限公司 | A kind of Chinese medicine composition and preparation method thereof |
| CN112656899A (en) * | 2021-01-25 | 2021-04-16 | 余俊严 | Pharmaceutical composition for treating neck, shoulder, waist and leg pain and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105055804A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN101129817A (en) | Chinese medicine formulation for treating hypertension and method of producing the same | |
| CN103340976B (en) | Drug for treating neck, shoulder, waist and leg pain | |
| CN113134064A (en) | Composition for preventing rheumatoid arthritis and preparation method and application thereof | |
| CN1539479A (en) | Drug for curing disease of proplapse of lumbar intervertebral disc | |
| CN102441145B (en) | Medicament for treating lumbar disc herniation and cervical spondylosis | |
| CN103893653A (en) | Traditional Chinese medicine for treating lumbar interveterbral disc protrusion | |
| CN103520432A (en) | Traditional Chinese medicine for treating qi-stagnation and blood stasis lumbar disc herniation and preparation method thereof | |
| CN101703662A (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN103446360B (en) | Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN101926905B (en) | Application of Chinese medicinal composition containing components for invigorating spleen and reducing phlegm in preparing medicine for treating early and medium stage femoral head necrosis | |
| CN115154537A (en) | Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion and application thereof | |
| CN100998681A (en) | Traditional Chinese medicine composition for treating prolapse of lumbar intervertebral disc shift | |
| CN1067571C (en) | Chinese medicine capsule for treating lumbar and cervical protrusion | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN103784604A (en) | Traditional Chinese medicine composition for treating protrusion of lumbar intervertebral disc, and preparation process and application thereof | |
| CN104491832A (en) | Traditional Chinese medicine composition used for treating osteoproliferation | |
| CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
| CN103656194A (en) | A traditional Chinese medicine decoction used for treating lubar intervertebral disc protrusion | |
| CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN102805795B (en) | Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof | |
| CN104524346A (en) | Traditional Chinese medicine composition for treating lumbar intervertebral disc herniation | |
| CN1313121C (en) | Application of ciliate bugle herb piece in preparing medicine for treating cervical spondylosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151118 |